Last Updated: August 4, 2026

CLINICAL TRIALS PROFILE FOR VIIBRYD

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VIIBRYD

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01473381 ↗	Safety and Efficacy of Vilazodone in Major Depressive Disorder	Completed	Forest Laboratories	Phase 4	2011-12-01	The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
NCT01473394 ↗	Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder	Completed	Forest Laboratories	Phase 4	2011-12-01	The purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major depressive disorder.
NCT01573598 ↗	Safety and Efficacy of Vilazodone in Major Depressive Disorder	Completed	Forest Laboratories	Phase 4	2012-04-01	Safety and Efficacy of Vilazodone in Major Depressive Disorder
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VIIBRYD

Condition Name

Chart
Table

Condition Name for VIIBRYD
Intervention	Trials
Major Depressive Disorder	9
Major Depressive Disorder (MDD)	1
Marijuana Dependence	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VIIBRYD
Intervention	Trials
Depressive Disorder, Major	10
Depressive Disorder	10
Depression	10
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VIIBRYD

Trials by Country

Map
Table

Trials by Country for VIIBRYD
Location	Trials
United States	134
Ukraine	5
Serbia	4
Canada	4
Germany	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VIIBRYD
Location	Trials
Florida	7
California	7
Texas	7
New York	7
Massachusetts	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VIIBRYD

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VIIBRYD
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	4
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VIIBRYD
Clinical Trial Phase	Trials
Completed	13
Unknown status	1
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VIIBRYD

Sponsor Name

Chart
Table

Sponsor Name for VIIBRYD
Sponsor	Trials
Forest Laboratories	13
Thomas Jefferson University	1
New York State Psychiatric Institute	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VIIBRYD
Sponsor	Trials
Industry	13
Other	9
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.